Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

615
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
615
Principles of Drug Action01:24

Principles of Drug Action

7.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

749
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
749

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bifunctional Photocatalysts: Exploiting Proximity for Enhanced Reaction Performance.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Pyrophosphate-modified liposomes for bone-targeted delivery.

Journal of liposome research·2025
Same author

Late-stage peptide modification with salicylaldehyde tag enhances affinity for nuclear factor-kappa B essential modulator.

RSC chemical biology·2025
Same author

Achieving High Affinity for a Bacterial Lectin with Reversible Covalent Ligands.

Journal of medicinal chemistry·2024
Same author

Amine-Carbamate Self-Immolative Spacers Counterintuitively Release 3° Alcohol at Much Faster Rates than 1° Alcohol Payloads.

Chembiochem : a European journal of chemical biology·2024
Same author

<i>Ex vivo</i> mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker.

Frontiers in pharmacology·2023

Related Experiment Video

Updated: Dec 9, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.9K

Targeted Small-Molecule Conjugates: The Future is Now.

Alberto Dal Corso1

  • 1Dipartimento di Chimica, Università degli Studi di Milano, via C. Golgi, 19, 20133, Milan, Italy.

Chembiochem : a European Journal of Chemical Biology
|September 7, 2020
PubMed
Summary

Novel small hetero-bifunctional compounds show promise for treating cancer and other diseases. Advances in drug development and delivery technologies are enabling targeted therapeutics for various pathologies.

Keywords:
conjugatesdrug deliveryfluorescenceimaging agentsradiopharmaceuticals

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.7K

Related Experiment Videos

Last Updated: Dec 9, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

9.9K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.7K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Oncology

Background:

  • Small hetero-bifunctional compounds are emerging as versatile tools in medicine.
  • These compounds are being explored for applications including cancer treatment, imaging, immunotherapy, and protein degradation.

Purpose of the Study:

  • To highlight the development and potential of novel small hetero-bifunctional compounds.
  • To discuss the impact of recent advancements on targeted therapeutic strategies.

Main Methods:

  • Review of recent progresses in ligand-screening procedures.
  • Analysis of hit-to-lead optimization strategies.
  • Examination of advances in drug-release technologies.

Main Results:

  • Development of novel classes of small hetero-bifunctional compounds.
  • Identification of diverse therapeutic applications, including radio/chemotherapy, imaging, immunotherapy, and protein degradation.
  • Progress in optimizing these compounds for targeted delivery and efficacy.

Conclusions:

  • Small hetero-bifunctional compounds represent a promising frontier in targeted therapeutics.
  • Continued advancements in drug development and delivery are expected to broaden their application in treating a wide range of diseases.
  • These targeted therapeutics hold potential for future personalized medicine approaches.